The Neuroendocrine Tumor Program, a collaboration between LSU Health Sciences Center and Ochsner Medical Center in Kenner, specializes in the diagnosis and management of all forms of neuroendocrine tumors (NETs). Our group, also known as the New Orleans, LA Neuroendocrine Tumor Specialists (NOLANETS), utilizes a multi-disciplinary approach that includes specialists in medical oncology, surgical oncology, transplantation, nuclear medicine, gastroenterology, and dietetics/nutritional support. With over 50 years of combined experience, our staff works with referring physicians and their patients to help diagnose and manage this rare disease.


Mary Maluccio, M.D., FACS

  • Chief, Section of Surgical Oncology
  • Professor of Surgery, LSU Health Sciences Center, Department of Surgery
  • Director of the Neuroendocrine Tumor Program, Ochsner Medical Center-Kenner
  • The James D. Rives Professor of Surgery and Neurosciences

J. Philip Boudreaux, M.D. FACS

  • Professor of Surgery, LSU Health Sciences Center, Department of Surgery
  • Chairman of Surgery, Ochsner Medical Center - Kenner

T. Ramcharan, M.B.B.S., FACS

  • Professor of Clinical Surgery, LSU Health Sciences Center, Department of Surgery

Daniel Raines, M.D., FACG

  • Section Chief of Gastroenterology
  • Associate Professor of Clinical Medicine

Virendra Joshi, M.D., FACP, AGAF

  • Director of Endoscopy & Hepatobiliary Services, Ochsner Medical Center-Kenner

Robert A. Ramirez, D.O., FACP

  • Hematologist & Medical Oncologist, Ochsner Medical Center-Kenner

Adam Dowling, M.D.

  • Interventional Radiologist, Ochsner Medical Center-Kenner

Richard J. Campeau, M.D., FACNM

  • Clinical Professor of Radiology & Internal Medicine, LSUHSC & Tulane

Ryan Majoria, M.D.

  • Interventional Radiologist, Our Lady of the Lake RMC-Baton Rouge, Ochsner Medical Center-Kenner

Alberto DeHoyos, M.D., FCCP, FACS

  • Director of Robotic & Minimally Invasive Thoracic Surgery, Ochsner Medical Center

Susan Gunn, M.D.

  • Pulmonary Services, Ochsner Medical Center




We offer local, regional, and systemic forms of therapy. Our group is actively involved in the development of novel therapeutic agents and performs gene analysis to identify which treatment could work best for each patient. We have access to cutting-edge clinical trials, hold thirteen patents in the field of endocrine oncology, and have authored over 125 peer reviewed publications.

In addition, we have sponsored multiple regional and national NET patient conferences which highlight the current treatments options for patients. These conferences explore novel avenues for research. Our doctors are constantly making their presence felt at national and regional cancer conferences, such as the Southern Surgical Association, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO), by presenting their research in neuroendocrine oncology.

2015 4:39:11 PM

The figure above shows our multi-disciplinary approach to the diagnosis and management of patients with neuroendocrine tumors.


2015 9:21:11 AM

The figure above illustrates the multitude of locations of primary neuroendocrine tumors we have seen in our clinic. On average, we see 10 new patients per week and 30 established patients per week. Since our initiation in 2006, we have seen over 2,000 patients with a neuroendocrine malignancy, making us one of the largest single institution’s in the United States.